Modulation of the immune response to vaccine antigensBROWN, Fred; HAAHEIM, Lars R.Developments in biological standardization. 1998, Num 92, issn 0301-5149, 380 p.Conference Proceedings

Adjuvants in perspectiveVOGEL, F. R.Developments in biological standardization. 1998, Num 92, pp 241-248, issn 0301-5149Conference Paper

Induction of virus-specific immunity by iscomsOSTERHAUS, A. D. M. E; RIMMELZWAAN, G. F.Developments in biological standardization. 1998, Num 92, pp 49-58, issn 0301-5149Conference Paper

The mode of action of immunological adjuvantsALLISON, A. C.Developments in biological standardization. 1998, Num 92, pp 3-11, issn 0301-5149Conference Paper

Will adjuvants be needed for vaccines of the future?BOMFORD, R.Developments in biological standardization. 1998, Num 92, pp 13-17, issn 0301-5149Conference Paper

Adjuvants and delivery systems for viral vaccines : Mechanisms and potentialJENNINGS, R; SIMMS, J. R; HEATH, A. W et al.Developments in biological standardization. 1998, Num 92, pp 19-28, issn 0301-5149Conference Paper

Humoral response to HSV-1 subunit vaccines : A statistical analysisSIMMS, J. R; HEATH, A. W; RICHARDSON, V. J et al.Developments in biological standardization. 1998, Num 92, pp 335-340, issn 0301-5149Conference Paper

Lipidation as a novel approach to mucosal immunizationTAM, J. P; MORA, A. L; RAO, C et al.Developments in biological standardization. 1998, Num 92, pp 109-116, issn 0301-5149Conference Paper

QS-21 and QS-7 : Purified saponin adjuvantsKENSIL, C. R; WU, J.-Y; ANDERSON, C et al.Developments in biological standardization. 1998, Num 92, pp 41-47, issn 0301-5149Conference Paper

Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantHANEBERG, B; DALSEG, R; MICHAELSEN, T. E et al.Developments in biological standardization. 1998, Num 92, pp 127-133, issn 0301-5149Conference Paper

Biodegradable polymer microspheres as vaccine adjuvants and delivery systemsGUPTA, R. K; CHANG, A.-C; SIBER, G. R et al.Developments in biological standardization. 1998, Num 92, pp 63-78, issn 0301-5149Conference Paper

Cellular and molecular mechanisms for induction of mucosal immunityBRANDTZAEG, P; FARSTAD, I. N; HARALDSEN, G et al.Developments in biological standardization. 1998, Num 92, pp 93-108, issn 0301-5149Conference Paper

Cellular immune responses of cattle to Cowdria ruminantiumMWANGI, D. M; MCKEEVER, D. J; MAHAN, S. M et al.Developments in biological standardization. 1998, Num 92, pp 309-315, issn 0301-5149Conference Paper

Cytotoxic activity induced by mycobacterium bovis BCGGHEORGHIU, M; LAGRANDERIE, M; BALAZUC, A. M et al.Developments in biological standardization. 1998, Num 92, pp 199-208, issn 0301-5149Conference Paper

Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery systemCRYZ, S. J; GLÜCK, R.Developments in biological standardization. 1998, Num 92, pp 219-223, issn 0301-5149Conference Paper

Nucleic acid vaccines against hepatitis virusesHOWARD, C. R; GRAY, L; D'MELLO, D et al.Developments in biological standardization. 1998, Num 92, pp 157-162, issn 0301-5149Conference Paper

Oral delivery of micro-encapsulated DNA vaccinesJONES, D. H; CLEGG, J. C. S; FARRAR, G. H et al.Developments in biological standardization. 1998, Num 92, pp 149-155, issn 0301-5149Conference Paper

PCPP as a parenteral adjuvant for diverse antigensPAYNE, L. G; VAN NEST, G; BARCHFELD, G. L et al.Developments in biological standardization. 1998, Num 92, pp 79-87, issn 0301-5149Conference Paper

Systematic development of a block copolymer adjuvant for trivalent influenza virus vaccineTODD, C. W; LEE, E; BALUSUBRAMANIAN, M et al.Developments in biological standardization. 1998, Num 92, pp 341-351, issn 0301-5149Conference Paper

The potential of retro-inverso peptides as synthetic vaccinesVAN REGENMORTEL, M. H. V; GUICHARD, G; BENKIRANE, N et al.Developments in biological standardization. 1998, Num 92, pp 139-143, issn 0301-5149Conference Paper

The role of cytotoxic T-cells in HIV infectionROWLAND-JONES, S; DONG, T; MACDONALD, K et al.Developments in biological standardization. 1998, Num 92, pp 209-214, issn 0301-5149Conference Paper

Antigen-independent activation of resting T-cells in the liver of patients with chronic hepatitisABRIGNANI, S.Developments in biological standardization. 1998, Num 92, pp 191-194, issn 0301-5149Conference Paper

Immune responses against hepatitis C virus structural proteins following genetic immunisationINCHAUSPE, G; MAJOR, M. E; NAKANO, I et al.Developments in biological standardization. 1998, Num 92, pp 163-168, issn 0301-5149Conference Paper

Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminantsMASLOG, F. S.Developments in biological standardization. 1998, Num 92, pp 301-307, issn 0301-5149Conference Paper

Iscom, a delivery system for parenteral and mucosal vaccinationMOREIN, B; VILLACRES-ERIKSSON, M; LÖVGREN-BENGTSSON, K et al.Developments in biological standardization. 1998, Num 92, pp 33-39, issn 0301-5149Conference Paper